Modern Healthcare December 12, 2017
Certain healthcare industry middlemen including pharmacy benefit managers, drug wholesalers and insurers will get squeezed out if they don’t adapt and reaffirm their value, according to a new report from PricewaterhouseCoopers.
Intermediaries like PBMs that work for payers to negotiate with pharmaceutical companies on the price of their products have been targeted for their role in huge price hikes that have plagued the industry. These middlemen should increase price transparency, deliver better pharmaceutical and clinical data to boost patient care, and diversify their business lines to secure their place in the industry, PwC’s Health Research Institute said in its annual report issued Tuesday.
Providers must expand beyond their sector or get left behind. They will need to form cross-sector relationships...
Today's Sponsors
Today's Sponsor